HYDERABAD, India – Despite reservations private equity players might have about a sector with longer gestation periods and stringent regulations, India's biopharmaceutical industry appears to be in an upbeat mood with new investments on the way and at least one state government announcing a land bonanza to set up biotech parks
NEW DELHI – Pharmaceutical manufacturers and policy makers in India are growing increasingly concerned about the country's dependence on China as the single source for bulk drugs and intermediary products that are necessary to the production of a wide range of products.
NEW DELHI – India plans to set up a new National Centre for Drug Discovery from Natural Products and strengthen its infrastructure and regulatory support for drugs trials, all part of its second national biotechnology research strategy unveiled recently.
NEW DELHI – India plans to set up a new National Centre for Drug Discovery from Natural Products and strengthen its infrastructure and regulatory support for drugs trials, all part of its second national biotechnology research strategy unveiled recently.
NEW DELHI – In another of several dramatic twists and turns over the past two years, India ended 2015 with a revision to its National List of Essential Medicines (NLEM), including some new drugs and knocking others off to raise the total number of medicines to 376.
NEW DELHI – Bangalore-based biotechnology start-up Pandorum Technologies Pvt Ltd. has developed artificial 3-D liver tissue that can mimic a human liver and be used in lieu of living tissue for human trials. The company said its artificial tissues and mini-organs are suitable for high-throughput drug and vaccine discovery, mechanistic toxicology and medical research, and that its ultimate vision is “on-demand manufacturing of human organs.”
NEW DELHI – In another of several dramatic twists and turns over the past two years, India ended 2015 with a revision to its National List of Essential Medicines (NLEM), including some new drugs and knocking others off to raise the total number of medicines to 376.
NEW DELHI – Bangalore-based biotechnology start-up Pandorum Technologies Pvt Ltd. has developed artificial 3-D liver tissue that can mimic a human liver and be used in lieu of living tissue for human trials. The company said its artificial tissues and mini-organs are suitable for high-throughput drug and vaccine discovery, mechanistic toxicology and medical research, and that its ultimate vision is "on-demand manufacturing of human organs."
